Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by bball67 on Jun 25, 2022 9:35am

1 for 60

Got an email this morning from my Interactive Brkoers account that I use for PMN.TO, notifying me of a reverse split of 1 for 60 effective 6/28/2022. Not making this up. Caught me by surprise.
Comment by bball67 on Jun 25, 2022 10:15am
A few more thoughts, I would expect a press release Monday morning stating that the the BOD approved a  1 for 60 split. Normally, there is a longer period of time before the effective date of a split but I am ok with getting it done fast. 
Comment by BottomBroker on Jun 25, 2022 10:42am
It would seem things are definitely starting to happen, and more quickly by the day. Interesting 6-8 months ahead, I think (hope). 
Comment by FarmerBetty on Jun 25, 2022 11:52am
The stock this week was at a 52 week low actually a 5 year low with the exception of 8 cents in Dec 2020. Have not mustered any type of deals after years of development in there programs providing addtional and additional testing with absolutely no interest from the investment community. Half of news releases attending conferences. If there is not some type of a licensing deal do you think Nasdaq ...more  
Comment by G1945V on Jun 25, 2022 12:50pm
"T.PMN | December 2, 2021 TORONTO and CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, is pleased to announce shareholders passed the share ...more  
Comment by Gbathat on Jun 26, 2022 11:41am
I'm glad they cleared some of the debt conversion to shares prior to this announcement, just in case we see volatility after the r/s.  Hopefully we don't, and we see a steady rise from here on with a few spikes with major milestones. R/S 1:60 puts us closer to $6/share... out of penny stock territory and onward towards the NASDAQ!   Good luck to all the longs.
Comment by G1945V on Jun 26, 2022 4:55pm
A big difference between a 60-to1 R/S and remaining on the TSX   vs. a 60-to-1 R/S and going on the Nasdaq. But if they stay on the TSX post R/S for too long we got problems. G1945V
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities